Six-Market Comparison: Philippine Registration Versus Malaysia, Indonesia, Vietnam, Thailand and Singapore

1. Key takeaways

Among the six ASEAN markets compared here, the Philippines sits in a middle-threshold position, with comparatively heavy documentation workflows and tightening enforcement. Classification follows the A–D four-tier scheme used in Malaysia, Indonesia and Singapore. The certificate is valid for 5 years (unlike Singapore, Thailand and Vietnam, where no fixed validity applies). Submissions are in English, but non-English documents must be translated, and foreign documents require notarisation plus Apostille (heavier than Singapore, lighter than Vietnam, Thailand and Indonesia).

• Classification is converged, not identical: five of the six markets use A–D, and Thailand is the exception.
• Low-risk pathways differ sharply, which changes market-entry cost for Class A product lines: Singapore exempts them, the Philippines uses CMDN, and Malaysia and Indonesia require full registration.
• Validity regimes split in two: fixed 5-year renewal versus maintenance by annual fee.
• Document legalisation is a Philippine advantage for Chinese applicants, thanks to the Hague Convention, which removes consular legalisation from the chain.
• Terminology does not travel; each market names its certificate differently, and borrowing one market’s label for another invites confusion in dossiers and in internal reporting.

2. Legal basis

The comparison below is drawn from the framework documents of each authority. It covers the elements that determine how a registration project is planned across markets. Read down the columns rather than across the rows: the classification column explains dossier reuse, the low-risk column explains cost, the validity column explains maintenance workload, and the legalisation column explains lead time.

3. Expert insights

Insight 1: on classification, the Philippines aligns with Malaysia, Indonesia, Singapore and Vietnam, with Thailand the only exception.

Thailand moved to a Class 1–4 system in 2019, and the earlier three-tier naming (ordinary controlled and specially controlled) is now historical. As a result, within the six ASEAN markets only Thailand uses numeric classes, while the other five use A–D letters. When reusing dossiers across markets, the Thai classification mapping must be handled separately, because a class number and a class letter convey different levels of control and cannot be converted by position alone.

Insight 2: low-risk devices are handled in three different ways across the six markets.

• Singapore: Class A is exempt from product registration and requires only a product notification;
• Philippines: Class A goes through CMDN notification, which produces a certificate but with a lighter dossier;
• Malaysia and Indonesia: there is no separate light pathway for low-risk devices, and Class A still requires full registration.

This directly affects the market-entry cost of low-risk product lines. The same Class A product line costs noticeably less to place on the market in Singapore and the Philippines than in Malaysia or Indonesia. For companies with a broad low-risk portfolio, the difference compounds across every model in the range.

Insight 3: validity regimes divide into fixed renewal and annual-fee maintenance.

• Philippines, Malaysia and Indonesia: the certificate runs for 5 years and is renewed at expiry;
• Vietnam and Thailand: no fixed validity (the Vietnamese số lưu hành has no fixed expiry);
• Singapore: no fixed validity but annual fees apply (Class B 39, C 67 and D 134 Singapore dollars), and the listing is cancelled if the fee is 60 days late.

For the licence holder, Vietnam, Thailand and Singapore carry lower maintenance cost but demand stricter administrative discipline, because renewal cannot be triggered by an expiry date and must be managed on a calendar. The Philippines, Malaysia and Indonesia have a clearer rhythm but concentrate workload once every 5 years. A single regional register that mixes both logics tends to fail on the calendar-driven markets first.

Insight 4: the document legalisation chain is a clear Philippine advantage over its neighbours.

The Hague Convention between China and the Philippines took effect on 7 November 2023, so Chinese public documents sent to the Philippines require only an Apostille and no consular legalisation. By contrast, Vietnam, Thailand and Indonesia still require embassy legalisation (Vietnam’s Apostille only takes effect on 11 September 2026). This makes the foreign document preparation stage noticeably shorter for the Philippines than for Vietnam, Thailand or Indonesia, and the saving applies to every document in the dossier rather than to a single certificate. It is one of the few points at which the Philippine route is structurally cheaper rather than merely different, and it is worth stating explicitly when a client compares markets for a first ASEAN submission.

4. Practical recommendations

• Use the A–D framework as the basis for multi-market dossier reuse, and map Thailand separately. Keep a conversion note for each product family rather than converting case by case.
• Choose the first market by low-risk pathway. Singapore and the Philippines are friendlier to Class A, and that should inform which market is used to test a new product line.
• Cost the legalisation chain by country in the project schedule. The Philippines (Apostille) is clearly faster than Vietnam, Thailand and Indonesia, and the difference should appear as a line item rather than an assumption.
• Match the register rules to the validity regime. Markets without fixed validity are managed by calendar; markets with fixed 5-year terms are managed by expiry date. Do not run both on the same reminder logic.

5. Verification checklist

• □ Classification confirmed (Philippines / Malaysia / Indonesia / Singapore / Vietnam: A–D; Thailand: 1–4)
• □ Low-risk pathway confirmed (Singapore: exempt; Philippines: CMDN; Malaysia / Indonesia: full registration)
• □ Validity regime confirmed (Philippines / Malaysia / Indonesia: 5 years; Vietnam / Thailand: no fixed term; Singapore: annual fee)
• □ Language requirements confirmed (local language in each market; English only in Singapore)
• □ Legalisation chain confirmed (Philippines: notarisation + Apostille, effective 7 November 2023)
• □ Market-specific terminology checked, with no cross-market substitution

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including the Philippines. Our team prepares CMDN/CMDR dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the FDA Philippines, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com